Drugs / Fecal Microbial Transplant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03426826 Comparator | Aug 2019 → Mar 2026 | autism spectrum disorder, digestive system disorder | Children's Hospital Los Angeles | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbial Transplant | “Active Comparator: Donor Stool Transplant Arm 2 will get FMT (Fecal Microbial Transplant) with Healthy Donor Stool into the jejunum through upper endoscopy.” NCT03426826 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03426826 ↗ |
| Modality | Other / unclassified | “Biological/Vaccine: Fecal Microbial Transplant versus placebo Fecal Transplant via endoscopy.” NCT03426826 ↗ |
| Route | Other | “into the jejunum through upper endoscopy” NCT03426826 ↗ |